.png)
.png)
Health 100 project introduces strategic shareholders of Alibaba, Ant Financial, Yunfeng Capital
【Date：2019.10.28 Source：English Web】
Health 100 project introduces strategic shareholders of Alibaba, Ant Financial, Yunfeng Capital
On October 27, Health 100 (002044) announced that Health 100 shareholders transferred 604,884,840 shares of Health 100 to Alibaba group, Ant Financial Services Group and Yunfeng Capital, accounting for 16.16% of the total equity of Health 100. After acquiring about 10.82% of Health 100 shares, Alibaba and its related parties will become the second largest shareholder of Health 100 after the completion of the transaction.
As a leading company in preventive medicine in China, Health 100 is committed to becoming a quality-driven professional medical service and life technology company relying on a large customer population, a professional service team, and a standardized medical service system throughout the country. Having imported the important strategic shareholders and partners such as Alibaba Group, Ant Financial Group and Yunfeng Capital, Health 100 will be promoted in digital and intelligent development level so as to establish a collaborative innovation technology platform.
Yu Rong, chairman of Health 100 Group has clearly pointed out for many times that "the health industry is an industry that needs long-term investment and deep cultivation. The product competitiveness of medical service enterprises should be based on the professional connotation, exploration of service experience, customer awareness and brand value. Sticking to the original intention, only through constantly improving the medical quality and service standards, can we become a professional medical service brand that wins consumers’ long-term trust, which is also the unswerving development logic of Health 100.
In the future, Health 100 will stick to the core strategy of strengthening the main business, raising standards and establishing ecology. Led by technology and driven by innovation, Health 100 will actively respond to the "Healthy China" initiative and fulfill its important mission to improve citizens' health and to promote the healthy development of the industry.
As a leading company in preventive medicine in China, Health 100 is committed to becoming a quality-driven professional medical service and life technology company relying on a large customer population, a professional service team, and a standardized medical service system throughout the country. Having imported the important strategic shareholders and partners such as Alibaba Group, Ant Financial Group and Yunfeng Capital, Health 100 will be promoted in digital and intelligent development level so as to establish a collaborative innovation technology platform.
Yu Rong, chairman of Health 100 Group has clearly pointed out for many times that "the health industry is an industry that needs long-term investment and deep cultivation. The product competitiveness of medical service enterprises should be based on the professional connotation, exploration of service experience, customer awareness and brand value. Sticking to the original intention, only through constantly improving the medical quality and service standards, can we become a professional medical service brand that wins consumers’ long-term trust, which is also the unswerving development logic of Health 100.
In the future, Health 100 will stick to the core strategy of strengthening the main business, raising standards and establishing ecology. Led by technology and driven by innovation, Health 100 will actively respond to the "Healthy China" initiative and fulfill its important mission to improve citizens' health and to promote the healthy development of the industry.
